Intrinsiqq
BetterLife Pharma Inc. logo

BetterLife Pharma Inc. Financials

BETRF

Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 5 of 8 available years
Income Statement
JAN 2018
JAN 2017
JAN 2016
JAN 2015
JAN 2013
General & Administrative$0$2$8$0$0
Research & Development$0––––
Total Operating Expenses$1$6$10$0–
Operating Income-$1-$6-$10-$0–
Non-Operating
Net Interest Expense-$0-$0–-$0-$0
Other Non-Operating Income (Expense)-$0-$0-$0-$0$0
Earnings from Continuing Ops––––-$0
Net Income
Net Income-$0-$6-$10-$1$0
EPS (Basic)-$0.00-$0.08-$0.11-$0.10$0.00
EPS (Diluted)-$0.00-$0.08-$0.11-$0.10$0.00
Weighted Avg Shares (Basic)79.9M75.3M77.7M11.6M35.8M
Weighted Avg Shares (Diluted)79.9M75.3M77.7M––
Shares Outstanding79.9M75.3M77.7M65.9M71.5M

BetterLife Pharma (BETRF) financials: revenue, profit and margins

BetterLife Pharma (BETRF) generated about n/a in revenue and -$7 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is BetterLife Pharma profitable?+

BetterLife Pharma reported about -$7 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 18 Dec 2018, covering the period ending 31 Oct 2018, as reported to the SEC. Data last refreshed 12 Oct 2026. How this is calculated.

Fiscal year ends Jan.

Peers

Pharmaceutical Preparations · Pick stocks to compare with BETRF

CompareIntrinsic value
LGVNLongeveron Inc.
$1.66-8.79%10
ALXOAlx Oncology Holdings Inc.
$1.07+4.41%10
BPTHBio-Path Holdings Inc.
$0.00+0.00%20
CYDYCytoDyn Inc.
$0.22-3.43%0
LIFDLftd Partners Inc.
$0.11+0.00%35
OMEROmeros Corporation
$13.21-5.71%28
TXMDTherapeuticsMD, Inc.
$1.71-5.52%29
VREOFVireo Growth Inc.
$5.23-2.24%30

Spot a number that looks wrong? Check it in BETRF's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing BETRF

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.